Nationwide Fund Advisors - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2017$320,000
+15.9%
111,7570.0%0.00%0.0%
Q2 2017$276,000
-29.2%
111,757
+3.5%
0.00%
-50.0%
Q1 2017$390,000
-10.6%
108,015
-12.2%
0.00%0.0%
Q4 2016$436,000
-16.6%
123,053
-5.0%
0.00%0.0%
Q3 2016$523,000
-17.1%
129,574
-9.9%
0.00%
-33.3%
Q2 2016$631,000
-13.3%
143,774
-25.3%
0.00%0.0%
Q1 2016$728,000
-59.6%
192,574
+67.4%
0.00%
-62.5%
Q4 2015$1,804,000
+82.0%
115,044
+22.3%
0.01%
+100.0%
Q3 2015$991,000
-67.4%
94,048
-21.9%
0.00%
-66.7%
Q2 2015$3,036,000
-22.1%
120,368
-14.0%
0.01%
-25.0%
Q1 2015$3,899,000
+99.6%
139,913
+30.7%
0.02%
+100.0%
Q4 2014$1,953,000
+48.3%
107,029
+5.3%
0.01%
+33.3%
Q3 2014$1,317,000
-20.5%
101,655
+0.1%
0.01%
-14.3%
Q2 2014$1,657,000
+5.7%
101,544
+14.4%
0.01%0.0%
Q1 2014$1,568,000
-29.2%
88,747
-2.9%
0.01%
-22.2%
Q4 2013$2,214,000
-43.1%
91,438
-16.7%
0.01%
-47.1%
Q3 2013$3,891,000
+129.6%
109,824
+1.2%
0.02%
+88.9%
Q2 2013$1,695,000108,5560.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders